Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
6.641 USD | +0.16% | -3.27% | -5.13% |
05-17 | HC Wainwright Adjusts Kala Pharmaceuticals Price Target to $18 From $21, Maintains Buy Rating | MT |
04-02 | HC Wainwright Trims KALA BIO's Price Target to $21 From $22, Keeps Buy Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-5.13% | 18.67M | |
+37.93% | 705B | |
+32.82% | 583B | |
-3.60% | 364B | |
+20.18% | 332B | |
+5.12% | 291B | |
+16.64% | 238B | |
-4.13% | 210B | |
+10.63% | 209B | |
+8.78% | 169B |
- Stock Market
- Equities
- KALA Stock
- News KALA BIO, Inc.
- HC Wainwright Adjusts Kala Pharmaceuticals' Price Target to $6 from $9, Keeps Buy Rating